Abstract
The current state of biomedical science is such that both the number and sophistication of methods available to investigate the genetic determinants of disease is unprecedented. For example, the introduction of high-throughput technologies such as DNA microarrays, allow researchers to comprehensively assess the human genome for single nucleotide polymorphisms that confer genetic susceptibility. Indeed, while these, and other similarly sophisticated methods, have yielded notable findings with regard to identification of risk variants in diseases such as diabetes, obesity, and glaucoma, similar studies of neuropsychiatric diseases such as schizophrenia and bipolar disorder have been somewhat less successful in producing strong findings. The reasons why this is the case are numerous, but likely refl ect the very complex genetic architecture of neuropsychiatric conditions. In this chapter, we consider an approach to addressing this complexity that involves the use of what are termed ‘endophenotypes’ (or alternatively ‘intermediate phe-notypes’) in genetic studies of neuropsychiatric disorders. Endophenotypes are biological changes, such as brain structural differences, that are thought to represent underlying molecular, physiologic, or otherwise subclinical changes resulting directly from the genetic variations that mediate susceptibility to overt clinical disease. Furthermore, neuroimaging phenotypes are, for a variety of reasons, thought to represent good candidate endophenotypes for genetic association studies of neuropsychiatric disease. Like high-dimensional genome-wide data, however, these phenotyping technologies can produce hundreds to thousands of data points or more, when all neuroanatomic regions and tissue types of interest are considered. The question then becomes, how can two or more high-dimensional data types (i.e., in this case genomic and neuroimaging) be leveraged, integrated, and analyzed in order to make valid inferences about the genetic basis of neuropsychi-atric disease? We comment on the analytic issues that arise when trying to leverage both genome-wide genetic data and neuroimaging data (e.g., problems related to multiple comparisons and false positives, as well as small sample sizes), and discuss four general approaches, each with its own set of advantages and disadvantages, that can be used in the analysis of imag-ing-genetics data. Finally, we provide a brief review of some of the recent studies that combine imaging and genetics, but note that the field, as a whole, is still very much in its infancy. We also provide suggestions for future directions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics. 2007;39:857–864
Hakonarson H, Grant SF, Bradfield JP, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature. 2007;448:591–594
Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (New York) 2007;316:889–894
Thorleifsson G, Magnusson KP, Sulem, P et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science (New York) 2007;317:1397–1400
Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nature Genetics. 2008;40:316–321
Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics. 2008;40:204–210
Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nature Genetics. 2008;40:395–402
Ridker PM, Pare G, Parker A, et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the women's genome health study. American Journal of Human Genetics. 2008;82:1185–1192
Tenesa A, Farrington SM, Prendergast JG, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genetics. 2008;40:631–637
Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638–642
Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thal-assemia. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:1620–1625
Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics. 2008;40:638–645
WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–678
Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. The Journal of Clinical Investigation. 2008;118:1590–1605
Lencz T, Morgan TV, Athanasiou M, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Molecular Psychiatry. 2007;12:572–580
Shifman S, Johannesson M, Bronstein M, et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genetics. 2008;4:e28
Kirov G, Zaharieva I, Georgieva L, et al. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Molecular Psychiatry. 2008 advance online publication, II March 2008 (DOI 10.1038/mp.2008.33)
Sklar P, Smoller JW, Fan J, et al. Whole-genome association study of bipolar disorder. Molecular Psychiatry. 2008;13:558–569
Baum AE, Akula N, Cabanero M, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Molecular Psychiatry. 2008;13:197–207
Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime? Trends in Genetics. 2006; 22:306–313
APA. Diagnostic and Statistical Manual of Mental Disorders. 4-Text Revision ed. Washington, DC: APA, 2000
Tan H Y, Callicott JH, Weinberger DR. Endophenotypes in schizophrenia genetics redux: is it a no brainer? Molecular Psychiatry. 2008;13:233–238
Callicott JH, Egan MF, Mattay VS, et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. The American Journal of Psychiatry. 2003;160:709–719
Goldman AL, Pezawas L, Mattay VS, et al. Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biological Psychiatry. 2008;63:475–483
Gottesman, II, Shields J. Genetic theorizing and schizophrenia. British Journal of Psychiatry. 1973;122:15–30
Toulopoulou T, Picchioni M, Rijsdijk F, et al. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Archives of General Psychiatry. 2007;64:1348–1355
Braff DL, Greenwood TA, Swerdlow NR, et al. Advances in endophenotyping schizophrenia. World Psychiatry. 2008;7:11–18
Braff D, Schork NJ, Gottesman, II. Endophenotyping schizophrenia. The American Journal of Psychiatry. 2007;164:705–707
Braff DL, Freedman R, Schork NJ, Gottesman, II. Deconstructing schizophrenia: an overview of the use of endopheno-types in order to understand a complex disorder. Schizophrenia Bulletin. 2007;33:21–32
Braff DL, Light GA. The use of neurophysiological endo-phenotypes to understand the genetic basis of schizophrenia. Dialogues in Clinical Neuroscience. 2005;7:125–135
Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychological Medicine. 2007;37:163–180
Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. The American Journal of Psychiatry. 2003;160:636–645
Fusar-Poli P, Perez J, Broome M, et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 2007;31:465–484
Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and cortical gyral patterns. Brain. 1997;120(Pt 2):257–269
MacDonald AW, 3rd, Carter CS. Event-related FMRI study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. Journal of Abnormal Psychology. 2003;112:689–697
Malhi GS, Lagopoulos J. Making sense of neuroimaging in psychiatry. Acta Psychiatrica Scandinavica. 2008;117:100–117
Bloss CS, Courchesne E. MRI neuroanatomy in young girls with autism: a preliminary study. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:515–523
Carper RA, Courchesne E. Localized enlargement of the frontal cortex in early autism. Biological Psychiatry. 2005; 57:126–133
Carper RA, Moses P, Tigue ZD, Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. NeuroImage. 2002;16:1038–1051
Courchesne E, Karns CM, Davis HR, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology. 2001;57:245–254
Kleinhans NM, Richards T, Sterling L, et al. Abnormal functional connectivity in autism spectrum disorders during face processing. Brain. 2008;131:1000–1012
Kleinhans NM, Johnson LC, Mahurin R, et al. Increased amygdala activation to neutral faces is associated with better face memory performance. Neuroreport. 2007;18:987–991
Bailer UF, Frank GK, Henry SE, et al. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Archives of General Psychiatry. 2005;62:1032–1041
Frank GK, Kaye WH. Positron emission tomography studies in eating disorders: multireceptor brain imaging, correlates with behavior and implications for pharmacotherapy. Nuclear Medicine and Biology. 2005;32:755–761
Kaye WH, Bailer UF, Frank GK, et al. Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiology & Behavior. 2005;86:15–17
Bertolino A, Weinberger DR. Proton magnetic resonance spectroscopy in schizophrenia. European Journal of Radiology. 1999;30:132–141
Bertolino A, Esposito G, Callicott JH, et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. The American Journal of Psychiatry. 2000; 157:26–33
Conturo TE, Lori NF, Cull TS, et al. Tracking neuronal fiber pathways in the living human brain. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:10422–10427
Mori S, Crain BJ, Chacko VP, van Zijl PC. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Annals of Neurology. 1999; 45:265–269
Pfefferbaum A, Rosenbloom MJ, Adalsteinsson E, Sullivan E V. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergis-tic white matter damage. Brain. 2007;130:48–64
Sullivan EV, Pfefferbaum A. Diffusion tensor imaging and aging. Neuroscience and Biobehavioral Reviews. 2006; 30:749–761
Straub RE, Weinberger DR. Schizophrenia genes — famine to feast. Biological Psychiatry. 2006;60:81–83
Meyer-Lindenberg A, Weinberger DR. Endophenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience. 2006;7:818–827
Meyer-Lindenberg A, Nicodemus KK, Egan MF, et al. False positives in imaging genetics. NeuroImage. 2008;40:655–661
Kriegeskorte N, Goebel R, Bandettini P. Information-based functional brain mapping. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:3863–3868
Balding DJ. A tutorial on statistical methods for population association studies. Nature Reviews. 2006;7:781–791
Fallin D, Cohen A, Essioux L, et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Research. 2001;11:143–151
Li Y, Sung WK, Liu JJ. Association mapping via regularized regression analysis of single-nucleotide-polymorphism hap-lotypes in variable-sized sliding windows. American Journal of Human Genetics. 2007;80:705–715
Tang Y, Ghosal S, Roy A. Nonparametric bayesian estimation of positive false discovery rates. Biometrics. 2007;63:1126–1134
Gadbury GL, Xiang Q, Yang L, et al. Evaluating statistical methods using plasmode data sets in the age of massive public databases: an illustration using false discovery rates. PLoS Genetics. 2008;4:e1000098
Schmidt S, Shao Y, Hauser ER, et al. Life after the screen: making sense of many P-values. Genetic Epidemiology. 2001;21 Suppl 1:S546–S551
Cucala L. A hypothesis-free multiple scan statistic with variable window. Biometrical Journal. 2008;50:299–310
Gordon D, Hoh J, Finch SJ, et al. Two approaches for consolidating results from genome scans of complex traits: selection methods and scan statistics. Genetic Epidemiology. 2001;21 Suppl 1:S396–402
Anderson TW. An Introduction to Multivariate Statistical Analysis. New York: Wiley, 1984
Tuncer Y, Tanik MM, Allison DB. An overview of statistical decomposition techniques applied to complex systems. Computational Statistics and Data Analysis. 2008;52:2292–2310
McIntosh AR, Bookstein FL, Haxby JV, Grady CL. Spatial pattern analysis of functional brain images using partial least squares. NeuroImage. 1996;3:143–157
Tura E, Turner JA, Fallon JH, et al. Multivariate analyses suggest genetic impacts on neurocircuitry in schizophrenia. Neuroreport. 2008;19:603–607
Nandy RR, Cordes D. Novel nonparametric approach to canonical correlation analysis with applications to low CNR functional MRI data. Magnetic Resonance in Medicine. 2003;50:354–365
Nievergelt CM, Libiger O, Schork NJ. Generalized analysis of molecular variance. PLoS Genetics. 2007;3:e51
Wessel J, Schork NJ. Generalized genomic distance-based regression methodology for multilocus association analysis. American Journal of Human Genetics. 2006;79:792–806
Zapala MA, Schork NJ. Multivariate regression analysis of distance matrices for testing associations between gene expression patterns and related variables. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103:19430–19435
Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature. 2004;429:883–891
Kaye WH, Bailer UF, Bloss CS, et al. 5-HT1A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups (submitted)
Manly B. Randomization, Bootstrap, and Monte Carlo Methods in Biology. London: Chapman & Hall, 1997
Neter J, Wasserman W, Kutner MH. Applied Linear Statistical Models. Homewood, IL: Richard D. Irwin, 1985
Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 1993;90:1977–1981
Chen K, Reiman EM, Alexander GE, et al. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. The American Journal of Psychiatry. 2007;164:916–921
Jak AJ, Houston WS, Nagel BJ, et al. Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dementia and Geriatric Cognitive Disorders. 2007;23:382–389
Espeseth T, Greenwood PM, Reinvang I, et al. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cognitive, Affective & Behavioral Neuroscience. 2006;6:31–43
Pezawas L, Verchinski BA, Mattay VS, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience. 2004;24:10099–10102
Durston S, Hulshoff Pol HE, Schnack HG, et al. Magnetic resonance imaging of boys with attention-deficit/hyperac-tivity disorder and their unaffected siblings. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:332–340
Pezawas L, Meyer-Lindenberg A, Drabant EM, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience. 2005;8:828–834
Surguladze SA, Elkin A, Ecker C, et al. Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces. Genes, Brain, and Behavior. 2008
Pohjalainen T, Nagren K, Syvalahti EK, Hietala J. The dop-amine D2 receptor 5′-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo. Pharmacogenetics. 1999;9:505–509
Laruelle M, Gelernter J, Innis RB. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Molecular Psychiatry. 1998;3:261–265
Marenco S, Steele SU, Egan MF, et al. Effect of metabotro-pic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. The American Journal of Psychiatry. 2006;163:740–742
McIntosh AM, Moorhead TW, Job D, et al. The effects of a neuregulin 1 variant on white matter density and integrity. Molecular Psychiatry. 2007
Honea RA, Meyer-Lindenberg A, Hobbs KB, et al. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biological Psychiatry. 2008;63:465–474
McIntosh AM, Job DE, Moorhead WJ, et al. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 2006;141B:76–83
Wobrock T, Kamer T, Roy A, et al. Reduction of the internal capsule in families affected with schizophrenia. Biological Psychiatry. 2008;63:65–71
Addington AM, Gornick MC, Shaw P, et al. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Molecular Psychiatry. 2007;12:195–205
Szeszko PR, Hodgkinson CA, Robinson DG, et al. DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. 2008;79:103–110
Tan H Y, Nicodemus KK, Chen Q, et al. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. The Journal of Clinical Investigation. 2008;118:2200–2208
Zinkstok J, Schmitz N, van Amelsvoort T, et al. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes, Brain, and Behavior. 2008;7:61–69
Benedetti F, Radaelli D, Bernasconi A, et al. Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes, Brain, and Behavior. 2008;7:20–25
Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:6917–6922
Lawrie SM, Hall J, McIntosh AM, et al. Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential. British Journal of Pharmacology. 2008;153 Suppl 1:S120–S124
Liu J, Pearlson G, Windemuth A, et al. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Human Brain Mapping. 2008 advance online publication, 10 Dec 2007 (DOI 10.1002/nbm.20508)
Straub RE, Lipska BK, Egan MF, et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Molecular Psychiatry. 2007;12:854–869
Lafuente A, Bernardo M, Mas S, et al. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyra-mi dal symptoms induced by antipsychotics. Schizophrenia Research. 2007;90:115–122
Papiol S, Molina V, Rosa A, et al. Effect of interleukin-1beta gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 2007;144B:1090–1093
Ho BC, Wassink TH, O'Leary DS, et al. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Molecular Psychiatry. 2005; 10:229, 287–298
Martinez D, Gelernter J, Abi-Dargham A, et al. The variable number of tandem repeats polymorphism of the dop-amine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology. 2001;24:553–560
Winterer G, Konrad A, Vucurevic G, et al. Association of 5′ end neuregulin-1 (NRG1) gene variation with subcorti-cal medial frontal microstructure in humans. NeuroImage. 2008;40:712–718
Kato T, Kunugi H, Nanko S, Kato N. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. American Journal of Medical Genetics. 2000;96:182–186
Roffman JL, Weiss AP, Goff DC, et al. Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia. Harvard Review of Psychiatry. 2006;14:78–91
Wang YX. Medical imaging in pharmaceutical clinical trials: what radiologists should know. Clinical Radiology. 2005;60:1051–1057
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bloss, C.S., Bakken, T.E., Joyner, A.H., Schork, N.J. (2009). Leveraging High-Dimensional Neuroimaging Data in Genetic Studies of Neuropsychiatric Disease. In: Ritsner, M.S. (eds) The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9464-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9464-4_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9463-7
Online ISBN: 978-1-4020-9464-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)